The device can spot problems in the body two weeks before the patient notices any symptoms, giving valuable time for intervention.
Vous n'êtes pas connecté
Pulnovo Medical Limited, a globally recognized device pioneer in the treatment of pulmonary hypertension (PH) and heart failure (HF), announced the successful initiation and first two patients enrollment for its
The device can spot problems in the body two weeks before the patient notices any symptoms, giving valuable time for intervention.
DALLAS, July 02, 2024 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence...
Beetroot juice has recently emerged as a star in natural health circles, particularly for its potential to lower high blood pressure, a condition also...
Microrobot-packed pill displays remarkable efficacy in combating inflammatory bowel disease in mice, heralding a new frontier in gastrointestinal...
The Queen Elizabeth Hospital (QEH) says the Accident and Emergency Department (AED) is currently experiencing a significant increase in the number...
High blood pressure, or hypertension, is a common condition among the elderly that can lead to serious health problems if not managed properly....
Below is a statement from the Queen Elizabeth Hospital The Accident and Emergency Department is currentlyexperiencing a significant increase in number...
WEDNESDAY, June 26, 2024 -- For patients with obesity-related heart failure with preserved ejection fraction (HFpEF), semaglutide reduces body weight...
Beam Therapeutics (BEAM) doses the first patient in a phase I/II study, evaluating in vivo base editor BEAM-302 for treating alpha-1 antitrypsin...